GLP-1s are just one wellbeing benefit that employers are covering in 2025
"You are getting hate for existing in a bigger body, which is messed up," says fashion journalist Evelyn Ebrey, who has just produced the documentary series Cutting the Curve, on plus-sized models
Latin America held a 3% share of the market in 2025 and is expected to grow at a significant CAGR of 14% during the projection period, driven by GLP-1 medications that are driving structural health and economic shifts across Latin America by curbing surging obesity and type-2 diabetes rates, spurring vast biopharma investments, and fundamentally changing consumer habits in the fast-moving consumer goods sector
All handling instructions are intended for laboratory use only
Week 3-4 (1 Month): With consistent weekly injections, improved diet, and regular exercise, some patients begin noticing changes in how their body processes fat
Key Benefits: More physiologic growth hormone pulses Reduced risk of side effects Often used in combination with GHRP peptides (like Ipamorelin or GHRP-2) for synergistic release Flexible dosing (often 5 days/week) Half-Life: ~30 minutes to 2 hours , depending on formulation and injection site CJC-1295 With DAC: The Extended-Release Option When CJC-1295 is formulated with DAC , its half-life extends up to 8 days , allowing for once-weekly dosing